The p53-dependent apoptotic pathway of breast cancer cells (BC-M1) induced by the bis-type bioreductive compound aziridinylnaphthoquinone.

Breast cancer research : BCR

Volumn 7, Issue 1, 2005, Pages

  Yang, Yu Ping ^a   Kuo, Hsien Shou ^a   Tsai, Hsin Da ^a   Peng, Yi Chen ^a   Lin, Yuh Ling ^a  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AZIRIDIN 1 YL 3 ((2 ((2 (3 AZIRIDIN 1 YL 1,4 DIOXO 1,4 DIHYDRONAPHTHALEN 2 YL)THIO)ETHOXY)ETHYL)THIO)NAPHTHOQUINONE; 2-AZIRIDIN-1-YL-3-((2-((2-(3-AZIRIDIN-1-YL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)THIO)ETHOXY)ETHYL)THIO)NAPHTHOQUINONE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; AZIRIDINE DERIVATIVE; NAPHTHOQUINONE; PACLITAXEL; PROTEIN P53; TAMOXIFEN;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; BREAST TUMOR; CELL CULTURE; FEMALE; GENETICS; HUMAN; PATHOLOGY; PHYSIOLOGY; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; AZIRIDINES; BLOTTING, WESTERN; BREAST NEOPLASMS; FEMALE; GENES, P53; HUMANS; NAPHTHOQUINONES; PACLITAXEL; TAMOXIFEN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33644830768     PISSN: None     EISSN: 1465542X     Source Type: Journal    
DOI: None     Document Type: Article

References (0)